Endo-and exocannabinoids, such as the psychoactive component of marijuana, exert their effects on brain function by inducing several forms of synaptic plasticity through the modulation of presynaptic vesicle release 1-3 . However, the molecular mechanisms underlying the widely expressed endocannabinoid-mediated long-term depression 3 (eCB-LTD), are poorly understood. Here, we reveal that eCB-LTD depends on the contractile properties of the pre-synaptic actomyosin cytoskeleton. Preventing this contractility, both directly by inhibiting non-muscle myosin II NMII ATPase and indirectly by inhibiting the upstream Rho-associated kinase ROCK, abolished long-term, but not short-term forms of cannabinoid-induced functional plasticity in both inhibitory hippocampal and excitatory cortico-striatal synapses. Furthermore, using 3D superresolution microscopy, we find an actomyosin contractility-dependent redistribution of synaptic vesicle pools within the presynaptic compartment following cannabinoid receptor activation, leading to vesicle clustering and depletion from the pre-synaptic active zone. These results suggest that cannabinoid-induced functional plasticity is mediated by a nanoscale structural reorganization of the presynaptic compartment produced by actomyosin contraction. By introducing the contractile NMII as an important actin binding/structuring protein in the dynamic regulation of synaptic function, our results open new perspectives in the understanding of mechanisms of synaptic and cognitive function, marijuana intoxication and psychiatric pathogenesis.
Introduction
Brain connectivity patterns arise through protracted developmental events that lead to assembly, activity-based selection and stabilization of synapses in the mature brain, through precise regulation of cytoskeletal dynamics. Importantly, synapses retain important functional plasticity, a critical component for experience-dependent adjustments of brain function. Both axons and presynaptic terminals undergo long-term experience and activity-dependent structural plasticity 4 , similar to postsynaptic dendritic spines, but molecular mechanisms are not well known. Several established and widespread forms of functional presynaptic plasticity throughout the mammalian brain are retrograde and endocannabinoid-mediated [1] [2] [3] . Activity-dependent release of endocannabinoids (eCBs) by the postsynaptic cell, followed by the activation of the presynaptic type-1 cannabinoid receptor (CB 1 R), mediates either a short-term depression (STD) of transmitter release, such as depolarization-induced suppression of inhibition (DSI) or excitation (DSE), or a long-term plasticity, such as eCB-mediated long-term depression (eCB-LTD) 3 . Although the mechanisms underlying DSI and DSE have been well established, the presynaptic mechanisms mediating eCB-LTD, much like other forms of long-term presynaptic plasticity, remain poorly understood.
Recently, we described a novel molecular mechanism through which the type-1 cannabinoid receptor (CB 1 R), an abundant and well-known mediator of synaptic plasticity in the adult brain, exerts neurodevelopmental effects in the embryonic brain 5 . In this mechanism, endo-and exocannabinoids, such as ∆ 9 THC, the psychoactive compound of marijuana, act through CB1Rs to induce non-muscle myosin II (NMII) contractility, downstream of the small the GTPase RhoA and Rhoassociated kinase (ROCK). This leads to axonal growth cone retraction and to rapid and lasting changes in the morphology of developing neurons 5 . Because mediators of neuronal development and neurite growth have been proposed to retain their structural roles in the mature brain, albeit on a smaller spatial scale 6 , we investigated here the possible involvement of this molecular mechanism in CB 1 R functions regulating synaptic plasticity in the mature brain by combining single-cell patchclamp recordings with a novel quantitative analysis of presynaptic nanoarchitecture.
Results and Discussion
First, we inhibited actomyosin contractility in acute brain slices from two different brain regions ( Fig.   1a, 2a) , during well-established forms of eCB-mediated STD and LTD, by preincubating slices for 20 minutes with blebbistatin (10μM), a selective NMII ATPase inhibitor 7 . In hippocampal slices of 6-8 weeks old mice, DSI, a STD of GABA release triggered by depolarization of pyramidal cells, was not affected by this treatment (Fig.1b) ; however, application of blebbistatin, but not of its inactive enantiomer, strikingly abolished the eCB-mediated LTD of inhibitory post-synaptic currents (IPSCs) ( Fig. 1c) . ROCK inhibition with the selective inhibitor Y-27632 (10μM) also fully blocked eCB-LTD induction ( Fig. 1h) . Blebbistatin application also abolished the change in release probability following eCB-LTD induction (as indirectly measured by the paired-pulse ratio PPR) ( Fig. 1d) , but did not affect the initial PPR ( Fig. 1d ). This indicates that blebbistatin prevented the eCB-mediated decrease in presynaptic vesicle release without altering basal transmission. In the hippocampus, induction of eCB-LTD requires not only CB 1 R activation, but also spontaneous firing of GABAergic interneurons.
We therefore tested whether blebbistatin might indirectly alter eCB-LTD by reducing interneuron firing. We found that blebbistatin did not change the amplitude or the frequency of spontaneous IPSCs (Fig. 1e.) . Furthermore, by applying a protocol capable of rescuing eCB-LTD when interneuron firing is blocked, using trains of stimulation following tetanus 8 , we found that eCB-LTD was still not induced in the presence of blebbistatin ( Fig. 1f.) . These data strongly indicate that blebbistatin is acting at presynaptic inhibitory terminals and is not altering interneuron activity. Finally, because eCB-LTD induction requires glutamate release, mGluR activation and eCB release, we bypassed all these steps and directly looked at the effect of CB 1 R activation with the high affinity agonist WIN55,212-2 9 on action potential-independent IPSCs, i.e. miniature IPSCs (mIPSCs). We found that WIN55,212-2 induced a significant decrease in the frequency but not the amplitude of mIPSCs, confirming the presynaptic origin of CB 1 R activation ( Fig. 1g) . Strikingly, in the presence of blebbistatin, WIN55,212-2 had no effect on mIPSC frequency ( Fig. 1g) .
While in the hippocampus eCB-induced plasticity is mostly present at inhibitory synapses, it is also widely expressed at excitatory synapses throughout the brain [1] [2] [3] . We therefore investigated the molecular mechanism of eCB-STD and LTD at an excitatory glutamatergic synapse: the corticostriatal synapse at medium-sized spiny neurons (MSNs) of the dorsolateral striatum ( Fig. 2a ) of young rats, which expresses eCB-mediated and CB 1 R-dependent STD, namely a DSE, and LTD 10, 11 . Here, a sustained depolarization of MSNs induced a DSE ( Fig. 2b) , which, similar to hippocampal DSI, was not significantly affected by blebbistatin (10μM) treatment ( Fig. 2b) . We then tested the striatal eCB-LTD induced after cortical low frequency stimulation (LFS) 10, 12 . This LTD was indeed CB 1 R-mediated as it was prevented by treatment with the CB 1 R specific inhibitor AM251 (3μM) ( Fig. 2c) . As for hippocampal synapses, actomyosin contraction was found to be necessary for corticostriatal eCB-LTD, which was prevented by treatment with blebbistatin, but not with the inactive blebbistatin enantiomer ( Fig. 2d) . This effect was not due to alterations in basal transmission as we found no significant change in PPR for 50ms intervals inter-stimuli in any tested condition ( Fig. 2e) . We further evaluated whether the effect of blebbistatin on eCB-LTD was pre-or postsynaptic by measuring the PPF ratio before and after LFS (PPF plasticity/baseline ). We found a significant increase in PPF in control conditions whereas no significant variation of PPF was found following treatment with active blebbistatin (Fig. 3f) , indicating presynaptic action of actomyosin contraction under eCB-LTD. The specific ROCK inhibitor Y-27632 (10μM) also impaired eCB-LTD induction ( Fig. 2g) . Therefore, similarly to hippocampal GABAergic synapses, activation of CB 1 R by eCBs in corticostriatal excitatory synapses induces LTD, but not STD, through ROCK-mediated presynaptic actomyosin contraction.
As blebbistatin directly inhibits the contractility of the actomyosin cytoskeleton, the effects described above suggest that cannabinoid-mediated LTD may be elicited through actomyosincontractility-induced cytoskeletal remodeling of the presynaptic compartment. In order to evaluate this hypothesis, we chose to directly image the nanoscale presynaptic architecture in dissociated cultures of rat hippocampal neurons. First, we confirmed that actomyosin contractility is involved in cannabinoid-induced synaptic plasticity in this experimental model by measuring the effect of CB 1 R activation on synaptic vesicle release at individual axonal boutons 13 , by using synaptophysin-pHluorin (SpH), which increases in green fluorescence intensity upon vesicle fusion 14 . Neuronal depolarization (KCl; 2min; 50mM) induced an average release of around 30% of total bouton vesicle pool under control conditions ( Fig. 3) , as estimated through maximal bouton fluorescence upon terminal alkaline incubation (NH 4 Cl; 2min, 50mM). Importantly, vesicle release under WIN55,212-2 (1µM; 10min) was significantly lower as compared to control ( Fig. 3) and this effect was prevented both by pretreating neurons with para-nitroblebbistatin (25µM, Fig. 3c ), a C15 derivative of blebbistatin 7 with reduced blue-light sensitivity 15 and neuronal cytotoxicity (Extended Data Fig. 1 ), as well as through pretreatment with Y-27632 (10µM, Fig. 3c ). Therefore, as in acute slices, activation of endogenous CB 1 R decreases vesicle release via ROCK-mediated NMII activation at individual axonal boutons in vitro.
We next assessed the nanoarchitecture of the presynaptic compartment and the potential influence of actomyosin dynamics by testing the spatial relationship between synaptic vesicles and the synaptic active zone (AZ) by using the activator/reporter pairing method of multicolor 3D Stochastic Optical Reconstruction Microscopy (STORM) 16 , which allows imaging proteins of interest simultaneously through the same optical path, reducing spatial differences that may arise through optical aberrations. Furthermore, to avoid any artifacts resulting from cross-talk of closely localized fluorophores, we used as a closely apposed but spatially separated spatial AZ reference Homer1, a major protein of the postsynaptic scaffold (PSD, Fig. 4a ). As pre-and post-synaptic compartments have to be precisely aligned inside individual synaptic nanomodules 17 in order to ensure sensitive and efficient detection of synaptic events, AZ and PSD synaptic scaffoldings are highly correlated 17, 18 ( Fig. 4b ), suggesting that AZ localization may be precisely predicted from the localization of the PSD scaffold. In order to verify this empirically, we measured the length, width, and depth of Homer1 and Bassoon (a major AZ scaffolding protein) appositions (Supp. Methods). All parameters were significantly correlated between corresponding appositions (n=140 over 3 independent experiments; Spearman's R for length: r=0.61, p<0.0001; width: r=0.55, p<0.0001; depth: r=0.34, p<0.0003) and the approximately 0.1 µm 2 mean area size of individual appositions (see Suppl. Methods) corresponds to the recently reported size of individual nanomodules 17 . Furthermore, distances between Homer1 and Bassoon protein clusters varied very little between synapses and were not affected under CB 1 R activation ( Fig. 4c-e ). Based on these properties, we were successfully able to predict the 3D location of the presynaptic AZ volume (AZv, Fig. 4f ) based on postsynaptic Homer1 clusters. Indeed, on an independent sample 95% of Bassoon locations were contained within our predicted AZv (Fig. 4g) .
We next immunolabeled synaptic vesicles for the SNARE protein VAMP2 (Fig. 4h) , and developed a nested clustering algorithm to identify synaptic vesicles within VAMP2 localisation clusters ( Fig.4j; Supp. Methods), to assess the spatial organization of the synaptic vesicles pool. We found strikingly fewer synaptic vesicles in the predicted AZv under WIN55,212-2 treatment (1µM, 10min), whereas pretreatment with para-nitroblebbistatin (25µM, 20min) significantly prevented this effect. (Fig.4k ).
Furthermore, synaptic vesicles were significantly more clustered to each other within the total pool under WIN55,212-2 treatment compared to either control conditions or para-nitroblebbistatin pretreatment (Fig.4l) . These results imply that CB 1 R activation induces a significant redistribution of synaptic vesicles within the presynaptic compartment following CB 1 R activation, leading to depletion of synaptic vesicles from the AZ. Inhibition of actomyosin contraction prevents both CB 1 R-induced vesicle redistribution and presynaptic silencing, suggesting that cannabinoid-induced changes in synaptic efficiency depend on the contractile properties of the presynaptic actomyosin cytoskeleton ( Fig.4m ).
In conclusion, in this study we have combined patch-clamp recordings with super resolution microscopy and functional imaging to establish the link between presynaptic architecture and synapse function at two archetypal CNS synapses. By showing that CB 1 R dynamically controls presynaptic organization associated to individual synaptic nanomodules 17 through actomyosin contractility, our results provide both a mechanism and a functional relevance to recent electron microscopy studies that reported fewer synaptic vesicles near the presynaptic active zone following cannabinoid treatment both in vitro and in vivo 13, 19 . Our results significantly extend the suggested roles for the presynaptic actin cytoskeleton, hopefully advancing toward a more complete model of regulation of vesicle release 20 . Structurally, synaptic vesicles are reversibly tethered to the actin cytoskeleton by synapsin, particularly vesicles of the recycling and/or resting pool 21 . Actin cytoskeleton dynamics also have an important role in the preferential distribution of recycling vesicles close to the AZ 22 . Our findings now identify another major actin binding/structuring protein, the contractile NMII, mechanistically explaining through dynamic redistribution of vesicles, the generation of a widespread form of long-term presynaptic plasticity. Notably, we did not find an effect of either NMII or ROCK inhibition on short-term forms of eCB-induced synaptic plasticity, neither on DSI nor DSE. Indeed, eCB-STD occur very rapidly (<1sec), following brief activation of CB 1 Rs, possibly effecting only already docked vesicles, while a longer CB 1 R activation (>5min) is necessary for eCB-LTD induction 23 . This longer activation period may be needed to engage actomyosin contraction, a molecular mechanism leading to actin cytoskeleton remodeling over several minutes in non-muscular cells 24 . Our results, by reporting a conceptually novel molecular mechanism of synaptic plasticity downstream of an important recreational drug target and known risk factor in schizophrenia 25 open novel perspectives in the understanding of cognitive function, the pathogenesis of marijuana intoxication and neuro-psychiatric disease.
Methods

Animals
Experiments were performed in accordance with local animal welfare committee (Center for Interdisciplinary Research in Biology and EU guidelines; directive 2010/63/EU). Rats and mice (Charles River, L'Arbresle, France) were housed in standard 12 hours light/dark cycles and food and water were available ad libitum.
Antibodies and Chemicals
Rabbit polyclonal Homer1 (Cat. No. 160 003) and mouse monoclonal VAMP2 (Cat. No. 104 211) antibodies were obtained from Synaptic Systems (Goettingen, Germany). Bassoon mouse monoclonal antibody (Cat. No. ab82958) was obtained from Abcam (Paris, France). Paired fluorophore-conjugated secondary antibodies were made as previously described 26 
Electrophysiological recordings and analysis from corticostriatal slices
330μm horizontal brain slices containing the somatosensory cortex and the corresponding corticostriatal projection field in the dorsolateral striatum were prepared from P 25-35 male rats as previously described 12, 27 . Brains were sliced in a 95% CO2/5% O2-bubbled, ice-cold cutting solution containing (in mM) 125 NaCl, 2.5 KCl, 25 glucose, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgCl 2 , 1 pyruvic acid, and then transferred into the same solution at 34°C for one hour and then moved to room temperature before patch-clamp whole-cell recordings (at 34°C).
Patch-clamp recordings were performed as previously described 12, 27 Current-clamp recordings were filtered at 2.5kHz and sampled at 5kHz and voltage-clamp recordings were filtered at 5kHz and sampled at 10kHz using the Patchmaster v2x32 program (HEKA Elektronik).
Electrical stimulations were performed with a bipolar electrode (Phymep) placed in the layer 5 of the somatosensory cortex and were monophasic at constant current (ISO-Flex stimulator) 10, 12, 27 .
Currents were adjusted to evoke striatal EPSCs ranging in amplitude from 50 to 200pA. Repetitive control stimuli were applied at a frequency of 0.1Hz for 60min after LFS protocol. Recordings on neurons were made over a period of 10 minutes at baseline, and for at least 60 minutes after the LFS protocols; long-term changes in synaptic efficacy were measured from 45 to 55 minutes. We individually measured and averaged 60 successive EPSCs, comparing the last 10 minutes of the recording with the 10-minute baseline recording. Series resistance was monitored for each sweep and a variation above 20% led to the rejection of the experiment. LTD was induced with low frequency stimulation protocol consisting in 600 cortical stimulations at 1Hz paired with postsynaptic concomitant depolarization of the MSN during 50ms 10, 12 . For DSE induction, MSN was depolarized from RMP to 0mV during 10sec (with bath-applied carbachol, 10μM, and DHPG, 50μM) 10 . Off-line analysis was performed using Fitmaster (Heka Elektronik) and Igor-Pro 6.0.3 (Wavemetrics, Lake Oswego, OR, USA). Statistical analysis was performed using Prism 5.0 software (San Diego, CA, USA). "n" refers to a single cell experiment from a single slice.
Immunocytochemistry and STORM imaging
Neurons used for STORM imaging underwent the same treatment protocol as for videomicroscopy at 21-28 DIV, with the exception that instead of depolarization with KCl after treatment, neurons were fixed with a preheated solution of 4% PFA and 4% sucrose in 0.1 M phosphate buffered saline (PBS) for 15 minutes at room temperature (RT), permeabilized after wash for 5 min at RT with 0.1% Triton X in PBS, and blocked for 1h at RT with blocking buffer (4% BSA in PBS). Primary and secondary antibodies were applied in blocking buffer, primary antibodies being applied overnight at 4°C and secondary antibodies being applied for 2h at RT. After washing out the secondary antibody, neurons were post-fixed with 4% PFA and 4% sucrose in PBS for 5min, washed and stored in PBS at 4°C before imaging. STORM images were acquired on a N-STORM microscope (Nikon Instruments), outfitted with 405 nm, 561 nm, and 647 nm solid-state lasers, a 100X NA 1.49 objective and an Ixon DU-897 camera.
Imaging was performed as previously described 26 . Briefly, visually identified dendrites labelled with activator-reporter fluorophore pairs (Alexa Fluor 405 -Alexa Fluor 647 and Cy3-Alexa Fluor 647) were imaged using sequences of one activator frame (405 or 561 nm) followed by three reporter frames (647 nm) 16 . A cylindrical lens was placed across the optical path in order to acquire 3D information 27 , and the N-STORM software (Nikon Instruments) was used for the localization of single fluorophores. (1) and (2) . 99±1% of baseline, n=5, p=0.37 with baseline and p=0.0004 with control LTD, n=6. Student's t-test. Values: mean± SEM. 
